Technology

Merit Medical Systems Inc. announced it has acquired the assets of Radial Assist, which include the Rad Board, Rad Board Xtra, Rad Trac and Rad Rest devices.

Home October 07, 2013
Home
Technology

Claron Technology will announce extended modality support for its Nil universal zero-footprint medical viewers at the Radiological Society of North America (RSNA) 2013 conference.

Home October 07, 2013
Home
News

With healthcare providers under continuing pressure to provide better care at lower costs, remote cardiac monitoring devices are becoming popular and valuable patient care tools, fueling U.S. market growth expected to top more than 25 percent between 2011 and 2016.

Home October 07, 2013
Home
News

Image Wisely recently launched its first Image Wisely Radiation Safety Case — a series of free, online and mobile-compatible educational offerings that allow radiologists, imaging technologists and medical physicists to assess their own understanding of important radiation safety concepts such as radiation dose monitoring and optimization. The first case, CT Dose and Size-Specific Dose Estimate (SSDE), offers a total of 0.5 AMA PRA Category 1 Credits, 0.5 MPCEC credit by the Commission on Accreditation of Medical Physics Education Programs Inc. and 0.5 Category A credit hours of the American Registry of Radiologic Technologists.

Home October 04, 2013
Home
Technology

Eizo Corp. and Stryker Corp. announced their partnership to offer customers integrated large monitor management systems suitable for use in standard and hybrid operating rooms. As a result of this partnership, Eizo will provide large monitors that can display multiple video sources simultaneously in conjunction with Stryker integrated operating suites. These configurable solutions will initially be offered in North America. Eizo’s platform includes large, medical-grade, high-resolution monitors up to 60 inches and the accompanying management system designed to allow users to change custom layouts

Home October 04, 2013
Home
News

Physicians at the Heart Hospital of Austin, enrolled and successfully treated the first patient in the Roadster study, a global, multicenter clinical trial evaluating the safety and efficacy of the Silk Road System for the treatment of carotid artery disease. Mazin I. Foteh, M.D., a vascular surgeon and principal investigator for the trial, performed the first procedure.

Home October 04, 2013
Home
News

A telestroke service increases the rate of effective tissue plasminogen activator (tPA) therapy for patients with acute ischemic stroke treated at community hospitals, according to a report in the October issue of Neurosurgery.

Home October 04, 2013
Home
Cath lab IMV market report
Feature

Purchasing activity for cardiac catheterization labs in the United States appears to be growing as more healthcare facilities look to replace aging equipment, according to a new report by IMV Medical Information Division. The census-based report finds that both patient volume and installed base are rising as the market recovers from a recent slowdown.

Home October 04, 2013
Home
News

According to the KLAS report Clinical Market Share 2013: More than Meaningful Use, Cerner Corporation and Epic Systems combined captured more than three-fourths of new large-hospital electronic medical records (EMR) contracts, while the other vendors struggled to keep pace.

Home October 03, 2013
Home
News

Immediate U.S. government furloughs affecting virtually all National Science Foundation (NSF) employees and three-fourths of those at the National Institutes of Health (NIH) could impact U.S. competitiveness, American Association for the Advancement of Science (AAAS) warned.

Home October 03, 2013
Home
News

EndoCross, Ltd. announced today that it has already enrolled one-third of the patients planned for the first-in-human study of its Enabler-C Catheter System for Crossing Coronary Chronic Total Occlusions (“Enabler 3C” study). The Enabler 3C clinical study is taking place at the Institut Cardiovasculaire Paris-Sud under principal investigator Dr. Yves Louvard.

Home October 03, 2013
Home
Technology

Delivering the precision, clinical sensitivity and clinical specificity necessary to assist physicians with the diagnosis of myocardial infarction (MI), Beckman Coulter Inc. announced the U.S. Food and Drug Administration (FDA) clearance of its new Access AccuTnI+3 troponin I assay for use on the UniCel DxI series of immunoassay systems.

Home October 03, 2013
Home
News

At RSNA 2013, GE will continue to demonstrate its innovations in low dose and high image quality in computed tomography (CT) imaging. The Discovery CT750 HD is the world's first high definition CT (HDCT), built with GE's exclusive Gemstone detector FREEdom Technologies. This allows for intelligent motion correction to “freeze” coronary motion, enhance coronary visualization and obtain additional information on plaque material composition. New this year is kV Assist, which provides optimized personalized scan settings and applications with automated kV and mA selection. kV Assist combined with SnapShot Assist deliver the desired image quality at the lowest possible dose and workflow optimizations for efficient cardiac CT.

Home October 03, 2013
Home
News

At RSNA 2013, GE Healthcare will showcase a range of molecular imaging tools designed to enable treatment evaluation earlier in a patient’s care pathway. Q.Suite, a collection of capabilities designed to extend quantitative positron emission tomography (PET) by generating more consistent standardized uptake value (SUV) readings, enabling clinicians to assess treatment response. Q.Suite is designed to help improve consistency of quantitative measurements in every key area: daily quality control, scanner workflow, motion correction, reconstruction algorithms and analysis and reporting applications. Controlling these variables to increase consistency can improve the clinician’s confidence that an SUV change has useful clinical meaning.

Home October 03, 2013
Home
Technology

When echocardiograms prove insufficient for diagnosis, Diagnosoft’s offers a patented and U.S. Food and Drug Administration 510(k)-cleared cardiac magnetic resonance imaging (CMR) solution for patient assessment. With benchmark sensitivity and specificity, the high throughput Diagnosoft CMR exam yields an advantageous alternative to nuclear or cardiac cath exams.

Home October 03, 2013
Home
Subscribe Now